标题
Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19
作者
关键词
-
出版物
Genes
Volume 11, Issue 9, Pages 1044
出版商
MDPI AG
发表日期
2020-09-04
DOI
10.3390/genes11091044
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- “Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era
- (2020) Donato Gemmati et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations
- (2020) Yanan Cao et al. Cell Discovery
- How ACE inhibitors transformed the renin–angiotensin system
- (2020) Y.S. Bakhle BRITISH JOURNAL OF PHARMACOLOGY
- A hypothesis for pathobiology and treatment of COVID‐19 : The centrality of ACE1 / ACE2 imbalance
- (2020) Krishna Sriram et al. BRITISH JOURNAL OF PHARMACOLOGY
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection
- (2020) Mostafa Saadat CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- ACE Ins/Del genetic polymorphism and epidemiological findings in COVID-19
- (2020) Joris R. Delanghe et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- COVID-19 infections are also affected by human ACE1 D/I polymorphism
- (2020) Joris R. Delanghe et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Risks of ACE Inhibitor and ARB Usage in COVID‐19: Evaluating the Evidence
- (2020) Krishna Sriram et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- An Imperative Need for Research on the Role of Environmental Factors in Transmission of Novel Coronavirus (COVID-19)
- (2020) Guangbo Qu et al. ENVIRONMENTAL SCIENCE & TECHNOLOGY
- Decreased Mortality of COVID-19 with Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension: A Meta-Analysis
- (2020) Xiaoming Guo et al. HYPERTENSION
- COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-Chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
- (2020) Donato Gemmati et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
- (2020) Murray Esler et al. JOURNAL OF HYPERTENSION
- ACE2 Activators for the Treatment of Covid 19 Patients
- (2020) Rafael Rodríguez‐Puertas JOURNAL OF MEDICAL VIROLOGY
- Clinical Implications of SARS-Cov2 Interaction with Renin Angiotensin System
- (2020) Agnieszka Brojakowska et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Sex and Gender Disparities in the COVID-19 Pandemic
- (2020) Jewel Gausman et al. JOURNAL OF WOMENS HEALTH
- Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic
- (2020) Andrew M. South et al. Nature Reviews Nephrology
- Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
- (2020) Giuseppe Mancia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
- (2020) Mandeep R. Mehra et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polygenic risk scores: from research tools to clinical instruments
- (2020) Cathryn M. Lewis et al. Genome Medicine
- Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2
- (2020) Adrien Breiman et al. PLoS Pathogens
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy
- (2020) Rosanna Asselta et al. Aging-US
- Single-cell RNA Expression Profiling of ACE2, The Receptor of SARS-CoV-2
- (2020) Yu Zhao et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Post-discharge thrombosis and hemorrhage in patients with COVID-19
- (2020) Rushad Patell et al. BLOOD
- ACE deletion allele is associated with susceptibility to SARS-CoV-2 infection and mortality rate: An epidemiological study in the Asian population
- (2020) Abhijit Pati et al. CLINICA CHIMICA ACTA
- The host’s angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections
- (2020) Joris R. Delanghe et al. CLINICA CHIMICA ACTA
- COVID19 in South Asians/Asian Indians: Heterogeneity of data and implications for pathophysiology and research
- (2020) Ritesh Gupta et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Letter to the Editor on “An Imperative Need for Research on the Role of Environmental Factors in Transmission of Novel Coronavirus (COVID-19)”, Back to Basics
- (2020) Kouji H. Harada et al. ENVIRONMENTAL SCIENCE & TECHNOLOGY
- Genetic gateways to COVID‐19 infection: Implications for risk, severity, and outcomes
- (2020) Monojit Debnath et al. FASEB JOURNAL
- Genomewide Association Study of Severe Covid-19 with Respiratory Failure
- (2020) David Ellinghaus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Besides population age structure, health and other demographic factors can contribute to understanding the COVID-19 burden
- (2020) Marília R. Nepomuceno et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol
- (2020) Marco Marietta et al. Trials
- Analysis of the Hosts and Transmission Paths of SARS-CoV-2 in the COVID-19 Outbreak
- (2020) Rui Dong et al. Genes
- Analysis of ACE2 Genetic Variability among Populations Highlights a Possible Link with COVID-19-Related Neurological Complications
- (2020) Claudia Strafella et al. Genes
- Addressing inequities in COVID-19 morbidity and mortality: research and policy recommendations
- (2020) Monica L Wang et al. Translational Behavioral Medicine
- Venous Thromboembolism among Hospitalized Patients with COVID-19 Undergoing Thromboprophylaxis: A Systematic Review and Meta-Analysis
- (2020) Gerald Chi et al. Journal of Clinical Medicine
- Spontaneous and severe haematomas in patients with COVID-19 on low-molecular-weight heparin for paroxysmal atrial fibrillation
- (2020) Maria Mazzitelli et al. Mediterranean Journal of Hematology and Infectious Diseases
- SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype
- (2020) Naoki Yamamoto et al. GENE
- Genetic associations between genes in the renin-angiotensin-aldosterone system and renal disease: a systematic review and meta-analysis
- (2019) Laura Jane Smyth et al. BMJ Open
- Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure
- (2019) Lauren B. Arendse et al. PHARMACOLOGICAL REVIEWS
- The combination of ACE I/D and ACE2 G8790A polymorphisms revels susceptibility to hypertension: A genetic association study in Brazilian patients
- (2019) Denise S. Pinheiro et al. PLoS One
- ABO blood group is a determinant of von Willebrand factor protein levels in human pulmonary endothelial cells
- (2019) Glenn P Murray et al. JOURNAL OF CLINICAL PATHOLOGY
- A Review of ACE Inhibitors and ARBs in Black Patients With Hypertension
- (2018) Allison Helmer et al. ANNALS OF PHARMACOTHERAPY
- Are genetic polymorphisms in the renin–angiotensin–aldosterone system associated with essential hypertension? Evidence from genome-wide association studies
- (2017) L-D Ji et al. JOURNAL OF HUMAN HYPERTENSION
- Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism
- (2017) Takanobu Takezako et al. PHARMACOLOGICAL RESEARCH
- AT2Receptors: Potential Therapeutic Targets for Hypertension
- (2016) Robert M. Carey AMERICAN JOURNAL OF HYPERTENSION
- TheACE2G8790A Polymorphism: Involvement in Type 2 Diabetes Mellitus Combined with Cerebral Stroke
- (2016) Yan-Hui Wu et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Novel RAAS agonists and antagonists: clinical applications and controversies
- (2015) Cesar A. Romero et al. Nature Reviews Endocrinology
- Similarities and differences of X and Y chromosome homologous genes, SRY and SOX3, in regulating the renin-angiotensin system promoters
- (2015) Fabiano C. Araujo et al. PHYSIOLOGICAL GENOMICS
- Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker
- (2014) M. Furuhashi et al. AMERICAN JOURNAL OF HYPERTENSION
- Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors
- (2014) Raphael N. Vuille-dit-Bille et al. AMINO ACIDS
- ABO blood group and von Willebrand factor: biological implications
- (2014) Massimo Franchini et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- A genetic variant inSLC6A20is associated with Type 2 diabetes in white-European and Chinese populations
- (2014) Y. Ling et al. DIABETIC MEDICINE
- The association between angiotensin-converting enzyme 2 polymorphisms and essential hypertension risk: A meta-analysis involving 14,122 patients
- (2014) Mei Yang et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Influence of ABO genotype and phenotype on angiotensin-converting enzyme plasma activity
- (2014) Patricia Gassó et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Rs495828 polymorphism of the ABO gene is a predictor of enalapril-induced cough in Chinese patients with essential hypertension
- (2014) Jian-Quan Luo et al. Pharmacogenetics and Genomics
- Calcium micro-depositions in jugular truncular venous malformations revealed by Synchrotron-based XRF imaging
- (2014) Lorella Pascolo et al. Scientific Reports
- From gene to protein—experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension
- (2014) Sheila K. Patel et al. Frontiers in Physiology
- Quantitative Variation in Plasma Angiotensin-I Converting Enzyme Activity Shows Allelic Heterogeneity in theABOBlood Group Locus
- (2013) Chikashi Terao et al. ANNALS OF HUMAN GENETICS
- Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects
- (2013) Manuel Haschke et al. CLINICAL PHARMACOKINETICS
- Rediscovering ACE: novel insights into the many roles of the angiotensin-converting enzyme
- (2013) Romer A. Gonzalez-Villalobos et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Gender difference of serum angiotensin-converting enzyme (ACE) activity in DD genotype of ACE insertion/deletion polymorphism in elderly Chinese
- (2013) Ya-Feng Zhang et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Olmesartan medoxomil treatment potently improves cardiac myosin-induced dilated cardiomyopathy via the modulation of ACE-2 and ANG 1–7 mas receptor
- (2012) Vijayakumar Sukumaran et al. FREE RADICAL RESEARCH
- Meta analysis of angiotensin-converting enzyme I/D polymorphism as a risk factor for preeclampsia in Chinese women
- (2012) W.G. Zhong et al. GENETICS AND MOLECULAR RESEARCH
- Lack of Association of ACE2 G8790A Gene Mutation with Essential Hypertension in the Chinese Population: A Meta-Analysis Involving 5260 Subjects
- (2012) Yan-yan Li Frontiers in Physiology
- Worldwide spatial genetic structure of angiotensin-converting enzyme gene: a new evolutionary ecological evidence for the thrifty genotype hypothesis
- (2011) Xiao Li et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1–7 mas receptor
- (2011) Vijayakumar Sukumaran et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- ADAM-17: the enzyme that does it all
- (2010) Monika Gooz CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- A genome-wide association study identifies new loci for ACE activity: potential implications for response to ACE inhibitor
- (2010) C-M Chung et al. PHARMACOGENOMICS JOURNAL
- Review: Interplay of Iron Metallobiology, Metalloproteinases, and FXIII, and Role of Their Gene Variants in Venous Leg Ulcer
- (2010) Ajay V Singh et al. International Journal of Lower Extremity Wounds
- Polymorphisms of angiotensin-converting enzyme (ACE) and ACE2 are not associated with orthostatic blood pressure dysregulation in hypertensive patients
- (2009) Xiao-han Fan et al. ACTA PHARMACOLOGICA SINICA
- Soluble Angiotensin-Converting Enzyme 2 in Human Heart Failure: Relation With Myocardial Function and Clinical Outcomes
- (2009) Slava Epelman et al. JOURNAL OF CARDIAC FAILURE
- Meta-analysis of association of ACE2 G8790A polymorphism with Chinese Han essential hypertension
- (2009) Jian-Bo Zhou et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Pharmacologic modulation of ACE2 expression
- (2008) María José Soler et al. CURRENT HYPERTENSION REPORTS
- Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies
- (2008) Patrice Guillon et al. GLYCOBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation